Alpha Tau Medical Ltd

詳細情報 Alpha Tau Medical Ltd 企業名

Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.

企業情報

企業コードDRTS

会社名Alpha Tau Medical Ltd

上場日Mar 08, 2022

最高経営責任者「CEO」Mr. Uzi Sofer

従業員数125

証券種類Ordinary Share

決算期末Mar 08

本社所在地Kiryat Hamada 5

都市JERUSALEM

証券取引所NASDAQ Capital Market Consolidated

国Israel

郵便番号9777605

電話番号97235774115

ウェブサイトhttps://www.alphatau.com/

企業コードDRTS

上場日Mar 08, 2022

最高経営責任者「CEO」Mr. Uzi Sofer

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Uzi Sofer

Chairman of the Board, Chief Executive Officer

11.52M

--

Mr. Michael Avruch

Independent Director

1.55M

+0.17%

Prof. Yona Keisari

Chief Scientific Officer

504.27K

+0.16%

Mr. Amnon Gat

Chief Operations Officer

68.47K

--

Mr. Raphi Levy

Chief Financial Officer

--

Prof. Itzhak Kelson

Chief Physics Officer

--

Dr. Robert Den, M.D.

Chief Medical Officer

--

Mr. Gary Leibler

Independent Director

--

Mr. Alan Adler

Independent Director

--

Dr. S. Morry Blumenfeld, Ph.D.

Independent Director

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Uzi Sofer

Chairman of the Board, Chief Executive Officer

11.52M

--

Mr. Michael Avruch

Independent Director

1.55M

+0.17%

Prof. Yona Keisari

Chief Scientific Officer

504.27K

+0.16%

Mr. Amnon Gat

Chief Operations Officer

68.47K

--

Mr. Raphi Levy

Chief Financial Officer

--

Prof. Itzhak Kelson

Chief Physics Officer

--

収益内訳

データなし

データなし

事業別

地域別

データなし

株主

更新時刻: Fri, May 16

株主統計

種類

株主統計

比率

Oramed Pharmaceuticals Inc

16.59%

Sofer (Uzi)

13.54%

Avruch (Michael)

1.82%

Hightower Advisors, LLC

0.81%

Keisari (Yona)

0.59%

他の

66.64%

株主統計

比率

Oramed Pharmaceuticals Inc

16.59%

Sofer (Uzi)

13.54%

Avruch (Michael)

1.82%

Hightower Advisors, LLC

0.81%

Keisari (Yona)

0.59%

他の

66.64%

種類

株主統計

比率

Corporation

16.59%

Individual Investor

16.20%

Investment Advisor

1.50%

Investment Advisor/Hedge Fund

0.62%

Hedge Fund

0.11%

Bank and Trust

0.04%

他の

64.94%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

54

29.36M

34.67%

+14.03M

2025Q1

56

19.44M

23.97%

-491.93K

2024Q4

55

19.31M

27.55%

-2.82M

2024Q3

59

19.28M

27.51%

-4.37M

2024Q2

62

19.31M

27.55%

-4.87M

2024Q1

65

19.84M

28.32%

-4.33M

2023Q4

137

22.06M

31.83%

-24.51M

2023Q3

140

32.52M

46.94%

-14.56M

2023Q2

146

33.02M

48.83%

-14.67M

2023Q1

145

32.68M

48.37%

-16.77M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Oramed Pharmaceuticals Inc

14.11M

16.66%

+14.11M

--

Apr 24, 2025

Sofer (Uzi)

11.52M

13.6%

--

Mar 01, 2025

Avruch (Michael)

1.55M

1.83%

+2.71K

+0.17%

Mar 01, 2025

Hightower Advisors, LLC

230.70K

0.27%

--

Mar 31, 2025

Keisari (Yona)

504.27K

0.6%

+781.00

+0.16%

Mar 01, 2025

HoyleCohen, LLC

269.09K

0.32%

--

Jun 30, 2024

Kovitz Investment Group Partners, LLC

226.32K

0.27%

+194.06K

+601.44%

Mar 31, 2025

Levin Capital Strategies, L.P.

222.51K

0.26%

-92.00K

-29.25%

Mar 31, 2025

Milch (David Mark)

88.74K

0.1%

-2.00K

-2.20%

Mar 01, 2025

Gat (Amnon)

68.47K

0.08%

--

Mar 01, 2025

詳細を見る

3.840USD

Alpha Tau Medical Ltd

3.840

概要

企業名

金融

分析